Evidence map›Paper›PMID 26511319›Full record

ArticleThe Journal of biological chemistry2015

Asn-150 of Murine Erythroid 5-Aminolevulinate Synthase Modulates the Catalytic Balance between the Rates of the Reversible Reaction.

Bosko M Stojanovski, Gloria C Ferreira

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bosko M StojanovskiFrom the Department of Molecular Medicine, Morsani College of Medicine, and.
Gloria C FerreiraFrom the Department of Molecular Medicine, Morsani College of Medicine, and the Department of Chemistry, University of South Florida, Tampa, Florida 33612 gferreir@health.usf.edu.
University of South Florida · US

Funding

Ferrochelatase: dose porphyrin distortion control metal ion specificity?R01GM080270 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI FERREIRA, GLORIA C. · 2007 to 2010
$916k
NIGMS NIH HHS GM080270NIGMS NIH HHS R01 GM080270
6 · The paper itself

Abstract

5-Aminolevulinate synthase (ALAS) catalyzes the first step in mammalian heme biosynthesis, the pyridoxal 5'-phosphate (PLP)-dependent and reversible reaction between glycine and succinyl-CoA to generate CoA, CO2, and 5-aminolevulinate (ALA). Apart from coordinating the positioning of succinyl-CoA, Rhodobacter capsulatus ALAS Asn-85 has a proposed role in regulating the opening of an active site channel. Here, we constructed a library of murine erythroid ALAS variants with substitutions at the position occupied by the analogous bacterial asparagine, screened for ALAS function, and characterized the catalytic properties of the N150H and N150F variants. Quinonoid intermediate formation occurred with a significantly reduced rate for either the N150H- or N150F-catalyzed condensation of glycine with succinyl-CoA during a single turnover. The introduced mutations caused modifications in the ALAS active site such that the resulting variants tipped the balance between the forward- and reverse-catalyzed reactions. Although wild-type ALAS catalyzes the conversion of ALA into the quinonoid intermediate at a rate 6.3-fold slower than the formation of the same quinonoid intermediate from glycine and succinyl-CoA, the N150F variant catalyzes the forward reaction at a mere 1.2-fold faster rate than that of the reverse reaction, and the N150H variant reverses the rate values with a 1.7-fold faster rate for the reverse reaction than that for the forward reaction. We conclude that the evolutionary selection of Asn-150 was significant for optimizing the forward enzymatic reaction at the expense of the reverse, thus ensuring that ALA is predominantly available for heme biosynthesis.

Indexed as

Amino Acid Substitution5-Aminolevulinate SynthetaseAcyl Coenzyme AAminolevulinic AcidAnimalsAsparagineBiocatalysisCatalytic DomainErythroid CellsGlycineKineticsMiceSubstrate Specificity5-Aminolevulinate SynthetaseAcyl Coenzyme AAminolevulinic AcidAsparagineGlycinesuccinyl-coenzyme A5-aminolevulinate synthaseenzyme mechanismenzyme mutationhemeporphyriaporphyrinpyridoxal phosphatereaction selectivitysideroblastic anemiasubstrate specificity

Identifiers

PMID26511319
PMCPMC4692205
OpenAlexW2167343075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.